日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study

中国晚期非小细胞肺癌ALK重排检测的真实世界数据(RATICAL):一项全国多中心回顾性研究

Li, Lin; Li, Wencai; Wu, Chunyan; Xi, Yanfeng; Guo, Lei; Ji, Yuan; Jiang, Lili; Li, Ji; Yun, Jingping; Chen, Gang; Li, Yuan; Liu, Yueping; Mu, Dianbin; Han, Yuchen; Sun, Leina; Xia, Qingxin; Teng, Xiaodong; Che, Nanying; Wu, Wei; Qiu, Xueshan; Liu, Chao; Yan, Xiaochu; Li, Daiqiang; Zhang, Zhihong; Wang, Zhe; Li, Yujun; Wang, Zheng; Guo, Lingchuan; Nie, Xiu; Geng, Jingshu; Zhou, Jianhua; Ying, Jianming

Breast Cancer Epidemiology and Survival Analysis of Shenyang in Northeast China: A Population-Based Study from 2008 to 2017

中国东北沈阳市乳腺癌流行病学及生存分析:一项基于人群的研究(2008年至2017年)

Su, Hongbo; Li, Xun; Lv, Yi; Qiu, Xueshan

Coexistence of Low-Grade Fetal Adenocarcinoma and Adenocarcinoma in situ of the Lung Harboring Different Genetic Mutations: A Case Report and Review of Literature

低级别胎儿腺癌与肺原位腺癌共存并携带不同基因突变:病例报告及文献复习

Liu, Shuli; Wang, Jinping; Luo, Xue; Li, Xiaoman; Miao, Yuan; Wang, Liang; Li, Qingchang; Qiu, Xueshan; Wang, En-Hua

Mixed granulosa-Sertoli sex cord-stromal tumor of the testis: clinical, ultrasonic and histopathological features: a case report

睾丸混合性颗粒细胞-支持细胞-性索间质肿瘤:临床、超声及组织病理学特征:病例报告

Sun, Mingfang; Liu, Yang; Yu, Juanhan; Diao, Kexin; Zhang, Jie; Qiu, Xueshan; Mi, Xiaoyi; Wang, Jian

M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer

M2巨噬细胞浸润肿瘤岛会导致非小细胞肺癌预后不良。

Cao, Lili; Che, Xiaofang; Qiu, Xueshan; Li, Zhi; Yang, Bowen; Wang, Shuo; Hou, Kezuo; Fan, Yibo; Qu, Xiujuan; Liu, Yunpeng

Prevalence of ROS1 fusion in Chinese patients with non-small cell lung cancer

中国非小细胞肺癌患者中ROS1融合的患病率

Zhang, Qing; Wu, Chunyan; Ding, Wei; Zhang, Zhihong; Qiu, Xueshan; Mu, Dianbin; Zhang, Haiqing; Xi, Yanfeng; Zhou, Jianhua; Ma, Liheng; Fu, Shijun; Gao, Min; Wang, Bo; Deng, Juan; Lin, Dongmei; Zhang, Jie

HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.

HDGF 和 ADAM9 是新型分子分期生物标志物、预后生物标志物和预测生物标志物,可用于手术切除的 I 期非小细胞肺癌的辅助化疗

Zhang Jun, Chen Ning, Qi Juan, Zhou Baosen, Qiu Xueshan

[Thymosin beta 10 prompted the VEGF-C expression in lung cancer cell]

[胸腺素β10促进肺癌细胞中VEGF-C的表达]

Li, Zixuan; Qu, Lianyue; Zhong, Hongshan; Xu, Ke; Qiu, Xueshan

[Application of the Ca2+ indicator fluo-3 and fluo-4 in the process of H2O2 induced apoptosis of A549 cell]

[Ca2+指示剂fluo-3和fluo-4在H2O2诱导A549细胞凋亡过程中的应用]

Zhang, Siyang; Li, Chunyan; Gao, Jian; Qiu, Xueshan; Cui, Zeshi

[Mechanism of thymosin beta 10 inhibiting the apoptosis 
and prompting proliferation in A549 cells]

[胸腺素β10抑制A549细胞凋亡并促进其增殖的机制]

Li, Zixuan; Qu, Lianyue; Zhong, Hongshan; Xu, Ke; Qiu, Xueshan